Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKesson
Boehringer Ingelheim
Express Scripts
McKinsey

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Phenylacetic acid

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Phenylacetic acid: Patents, clinical trial progress, indications

Phenylacetic acid is an investigational drug.

There have been 4 clinical trials for Phenylacetic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2017.

The most common disease conditions in clinical trials are Urea Cycle Disorders, Inborn, Disease, and Drug-Related Side Effects and Adverse Reactions. The leading clinical trial sponsors are Shijiazhuang Yiling Pharmaceutical Co. Ltd, Horizon Therapeutics, LLC, and Yiling Pharmaceutical Inc.

There are three US patents protecting this investigational drug and forty-one international patents.

Recent Clinical Trials for Phenylacetic acid
TitleSponsorPhase
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in ChinaShijiazhuang Yiling Pharmaceutical Co. LtdPhase 1
Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle DisordersHorizon Therapeutics, LLCPhase 4
A Phase I Clinical Study Trial of Felbinac Trometamol Injection in ChinaYiling Pharmaceutical Inc.Phase 1

See all Phenylacetic acid clinical trials

Clinical Trial Summary for Phenylacetic acid

Top disease conditions for Phenylacetic acid
Top clinical trial sponsors for Phenylacetic acid

See all Phenylacetic acid clinical trials

US Patents for Phenylacetic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Phenylacetic acid   Start Trial Method of diagnosing and treating cancer using B-catenin splice variants The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC)   Start Trial
Phenylacetic acid   Start Trial 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists Bristol-Myers Squibb Company (Princeton, NJ)   Start Trial
Phenylacetic acid   Start Trial Fused heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Phenylacetic acid   Start Trial Pyrrolidine amide compounds as histone demethylase inhibitors GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Phenylacetic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Phenylacetic acid Australia 2006213610 2025-02-10   Start Trial
Phenylacetic acid Canada 2596845 2025-02-10   Start Trial
Phenylacetic acid Denmark 1851340 2025-02-10   Start Trial
Phenylacetic acid European Patent Office 1851340 2025-02-10   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
McKesson
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.